View Author
scopus: 36060285500

Robinson, P.H.

(Peter Robinson)


placebo event incidence perforation nsaid rofecoxib patch number incidence rates celecoxib estimate ulcer trial etoricoxib stroke safety group figure study control valdecoxib meloxicam coxib review lumiracoxib peptic ulcer table patient incidence estimates nonsteroidal anti-inflammatory drugs duration al .22 mi meta-analysi reference method peptic information laparoscopic giant cells range article perforation site gi events anti-inflammatory omental arthritis closure giant n rate tnsaid stamp cv events 0.00 omentum result treatment non-steroidal anti-inflammatory drugs layer volume nonsteroidal evaluation osteoarthritis nabumetone stomach aspirin repair laparoscopic repair infarction 0.4 0.0 0.8 procedure inhibitor 1.6 stamp method surgery 1.2 knowledge gaps technique etodolac




2 Most Recent Publications

Cardiovascular and gastrointestinal safety of NSAIDs: A systematic review of meta-analyses of randomized clinical trials (Article)
Salvo, F. Fourrier-Reglat, A. Bazin, F. Robinson, P.H. Riera-Guardia, N. Haag, M.D.M. Caputi, A.P. Moore, N. Sturkenboom, M.C.J.M. Pariente, A.
2011-06-01
Comparison of closure of gastric perforation ulcers with biodegradable lactide-glycolide-caprolactone or omental patches (Article)
Bertleff, M.J.O.E. Stegmann, T. Liem, R.S.B. Kors, G. Robinson, P.H. Nicolai, J.P. Lange, J.F.
2009-10-01